Annemasse, France

Alain Robert

This inventor holds 6 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents. Top assignee: Pierre Fabre Medicament. Active years: 2005-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alain Robert. Retrieved from https://idiyas.com/inventor/alain-robert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2005-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alain Robert

Introduction

Alain Robert is a notable inventor based in Annemasse, France. He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 6 patents, Robert's work focuses on antibody-drug conjugates and their applications in oncology.

Latest Patents

Among his latest patents, Robert has developed an IGF-1R antibody-drug-conjugate designed for the treatment of cancer. This invention involves an antibody capable of binding to IGF-1R, which is conjugated to drugs derived from dolastatin 10 and auristatins. Additionally, he has patented an IGF-1R antibody that serves as an addressing vehicle for cancer treatment. This monoclonal antibody can induce internalization of IGF-1R, allowing it to be used in conjunction with other anti-cancer compounds.

Career Highlights

Throughout his career, Alain Robert has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and Pierre Fabre Médicament. His expertise in developing innovative cancer therapies has positioned him as a key figure in the field.

Collaborations

Robert has collaborated with notable colleagues such as Liliane Goetsch and Matthieu Broussas, contributing to the advancement of cancer treatment methodologies.

Conclusion

Alain Robert's innovative work in the development of antibody-drug conjugates highlights his commitment to improving cancer therapies. His contributions continue to influence the field and offer hope for more effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…